In contrast to trial evidence showing 1-year remission rates of 40%80%%, this study observed a lower effectiveness of 6-MP/AZA treatment, possibly due to differences in disease severity, patient demographics, comorbidity, adherence, and health care utilization.
Conclusions: We observed a decrease of effectiveness of severity scales over time, however this effectiveness remains optimal in all the severity scales except for MPM0.
Herein, we do observe a lower effectiveness of pandemic vaccines in preventing ILI after the epidemic period (VE = 33%, 4 55); however, unlike in Nichol et al, the effectiveness remains significantly above zero.
To improve search engine effectiveness, we have observed an increased interest in gathering additional feedback about users' information needs that goes beyond the queries they type in.
Over a 20 year time period, we do observe an increase in effectiveness by combination vaccines with MSTBV, compared to those without, especially with increasing half-life (results not shown).
We did observe a significantly higher effectiveness of pandemic vaccines in preventing laboratory-confirmed pandemic A(H1N1) influenza when only vaccinations dating back to more than three weeks were considered completed than when treating all vaccinations as completed: 86% (56 98) versus 49% (25 67).
Recently, several clinicians have observed the effectiveness of Yokukansan, a traditional Japanese medicine, in the treatment of the BPSD and in cognitive impairment of AD [1] [3].
These may incorporate a complex integration of factors including observed clinical effectiveness, what they rate as important and the views of the patient and sometimes the carer.
A randomized controlled trial (RCT) is performed to observe effectiveness and cost-effectiveness of case-management.
